An alarming trend: Up to 40 percent of Africans with HIV who start treatment discontinue it within one to three years, which can lead to viral strains resistant to less-expensive first-line medications, The New York Times reports. While earlier studies found adherence to medication in Africa was as high or higher than in the United States, that seems to no longer be the case; more people are opting out of treatment because of lack of child care, distance from a clinic, high cost of transportation or religious beliefs. HIV programs in Africa are now experimenting with ways to increase adherence, like offering a three-month supply of medication or reimbursing people for transportation.

To read the Times article, click here.